Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taro Yamanaka

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cells|March 12, 2025
Development of Antibody-Drug Conjugates for Malignancies of the Uterine Corpus: A ReviewTaro Yamanaka, Tadaaki Nishikawa, Hiroshi Yoshida
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 6, 2026
Illustrating the "Quiet Genome" Concept of SMARCA4-Deficient Uterine Sarcoma Via Whole-Exome Sequencing: A Highly Aggressive Case in a Young WomanHiroshi Yoshida, Kouya Shiraishi, Taro Yamanaka, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Endocrine Therapy for Endometrial Carcinoma: Current Evidence, Resistance Mechanisms, and Biomarker-Driven Patient SelectionTaro Yamanaka, Hiroshi Yoshida, Tatsunori Shimoi, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|January 3, 2024
[Evaluation of oral medications in the geriatric medical care ward based on the Guidelines for Appropriate Use of Medications for the Elderly (2018), and an analysis of the number of oral medicines in relation to the nutritional route and activities of daily living (ADL) categories]Hiroyuki Otsuka, Yuichiro Kawakami, Masato Shinozaki, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2023
Cabozantinib-induced serum creatine kinase elevation and rhabdomyolysis: a retrospective case seriesTaro Yamanaka, Kohji Takemura, Michikata Hayashida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2020
[Hypopituitarism]Taro Yamanaka, Keita Tatsushima, Chihiro Kondoh, et al.
IJU Case Reports|November 6, 2023
Complete response of metastatic papillary renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus cabozantinibMichikata Hayashida, Yuji Miura, Takeshi Yamaguchi, et al.
JCO Clinical Cancer Informatics|November 23, 2022
Efficacy of Telemedicine Using Videoconferencing Systems in Outpatient Care for Patients With Cancer: A Systematic Review and Meta-AnalysisYasuaki Uemoto, Taro Yamanaka, Yuki Kataoka, et al.
IJU Case Reports|July 7, 2022
Complete response of metastatic renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus ipilimumabMichikata Hayashida, Yuji Miura, Taisho Noda, et al.
IJU Case Reports|March 6, 2023
Bell's palsy during rechallenge of immune checkpoint inhibitorKohji Takemura, Taro Yamanaka, Michikata Hayashida, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cells|March 12, 2025
Development of Antibody-Drug Conjugates for Malignancies of the Uterine Corpus: A ReviewTaro Yamanaka, Tadaaki Nishikawa, Hiroshi Yoshida
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 6, 2026
Illustrating the "Quiet Genome" Concept of SMARCA4-Deficient Uterine Sarcoma Via Whole-Exome Sequencing: A Highly Aggressive Case in a Young WomanHiroshi Yoshida, Kouya Shiraishi, Taro Yamanaka, et al.
Current Oncology (Toronto, Ont.)|February 26, 2026
Endocrine Therapy for Endometrial Carcinoma: Current Evidence, Resistance Mechanisms, and Biomarker-Driven Patient SelectionTaro Yamanaka, Hiroshi Yoshida, Tatsunori Shimoi, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|January 3, 2024
[Evaluation of oral medications in the geriatric medical care ward based on the Guidelines for Appropriate Use of Medications for the Elderly (2018), and an analysis of the number of oral medicines in relation to the nutritional route and activities of daily living (ADL) categories]Hiroyuki Otsuka, Yuichiro Kawakami, Masato Shinozaki, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2023
Cabozantinib-induced serum creatine kinase elevation and rhabdomyolysis: a retrospective case seriesTaro Yamanaka, Kohji Takemura, Michikata Hayashida, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2020
[Hypopituitarism]Taro Yamanaka, Keita Tatsushima, Chihiro Kondoh, et al.
IJU Case Reports|November 6, 2023
Complete response of metastatic papillary renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus cabozantinibMichikata Hayashida, Yuji Miura, Takeshi Yamaguchi, et al.
JCO Clinical Cancer Informatics|November 23, 2022
Efficacy of Telemedicine Using Videoconferencing Systems in Outpatient Care for Patients With Cancer: A Systematic Review and Meta-AnalysisYasuaki Uemoto, Taro Yamanaka, Yuki Kataoka, et al.
IJU Case Reports|July 7, 2022
Complete response of metastatic renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus ipilimumabMichikata Hayashida, Yuji Miura, Taisho Noda, et al.
IJU Case Reports|March 6, 2023
Bell's palsy during rechallenge of immune checkpoint inhibitorKohji Takemura, Taro Yamanaka, Michikata Hayashida, et al.
Pageof 2